Literature DB >> 26873661

The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope.

Tianyi Qiu, Jingxuan Qiu, Jun Feng, Dingfeng Wu, Yiyan Yang, Kailin Tang, Zhiwei Cao, Ruixin Zhu.   

Abstract

As an extension of the conventional quantitative structure activity relationship models, proteochemometric (PCM) modelling is a computational method that can predict the bioactivity relations between multiple ligands and multiple targets. Traditional PCM modelling includes three essential elements: descriptors (including target descriptors, ligand descriptors and cross-term descriptors), bioactivity data and appropriate learning functions that link the descriptors to the bioactivity data. Since its appearance, PCM modelling has developed rapidly over the past decade by taking advantage of the progress of different descriptors and machine learning techniques, along with the increasing amounts of available bioactivity data. Specifically, the new emerging target descriptors and cross-term descriptors not only significantly increased the performance of PCM modelling but also expanded its application scope from traditional protein-ligand interaction to more abundant interactions, including protein-peptide, protein-DNA and even protein-protein interactions. In this review, target descriptors and cross-term descriptors, as well as the corresponding application scope, are intensively summarized. Additionally, we look forward to seeing PCM modelling extend into new application scopes, such as Target-Catalyst-Ligand systems, with the further development of descriptors, machine learning techniques and increasing amounts of available bioactivity data.
© The Author 2016. Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.

Keywords:  computer-aided drug design; cross-term descriptors; molecule descriptors; proteochemometric modelling; target descriptors

Mesh:

Substances:

Year:  2016        PMID: 26873661     DOI: 10.1093/bib/bbw004

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  9 in total

1.  Scoring Functions for Protein-Ligand Binding Affinity Prediction using Structure-Based Deep Learning: A Review.

Authors:  Rocco Meli; Garrett M Morris; Philip C Biggin
Journal:  Front Bioinform       Date:  2022-06-17

Review 2.  Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope.

Authors:  Arathi Kizhedath; Simon Wilkinson; Jarka Glassey
Journal:  Arch Toxicol       Date:  2016-10-20       Impact factor: 5.153

3.  Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling.

Authors:  Tianyi Qiu; Dingfeng Wu; Jingxuan Qiu; Zhiwei Cao
Journal:  J Cheminform       Date:  2018-04-12       Impact factor: 5.514

Review 4.  Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.

Authors:  Shaherin Basith; Minghua Cui; Stephani J Y Macalino; Jongmi Park; Nina A B Clavio; Soosung Kang; Sun Choi
Journal:  Front Pharmacol       Date:  2018-03-09       Impact factor: 5.810

Review 5.  Current computational methods for predicting protein interactions of natural products.

Authors:  Aurélien F A Moumbock; Jianyu Li; Pankaj Mishra; Mingjie Gao; Stefan Günther
Journal:  Comput Struct Biotechnol J       Date:  2019-10-28       Impact factor: 7.271

6.  Modeling cancer drug response through drug-specific informative genes.

Authors:  Luca Parca; Gerardo Pepe; Marco Pietrosanto; Giulio Galvan; Leonardo Galli; Antonio Palmeri; Marco Sciandrone; Fabrizio Ferrè; Gabriele Ausiello; Manuela Helmer-Citterich
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

7.  Prediction of Protein-ligand Interaction Based on Sequence Similarity and Ligand Structural Features.

Authors:  Dmitry Karasev; Boris Sobolev; Alexey Lagunin; Dmitry Filimonov; Vladimir Poroikov
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

Review 8.  Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery.

Authors:  Felipe Raposo Passos Mansoldo; Fabrizio Carta; Andrea Angeli; Veronica da Silva Cardoso; Claudiu T Supuran; Alane Beatriz Vermelho
Journal:  Molecules       Date:  2020-11-23       Impact factor: 4.411

Review 9.  Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.

Authors:  Ahmet Sureyya Rifaioglu; Heval Atas; Maria Jesus Martin; Rengul Cetin-Atalay; Volkan Atalay; Tunca Doğan
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.